"Recurrent Cancer" trang 1 - tải miễn phí từ tailieunhanh
Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: A retrospective study

Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: A retrospective study
9    116    0
Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): Rationale and design

Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): Rationale and design
7    84    1
A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA)
10    80    1
Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): Study protocol for a randomised phase III trial

Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): Study protocol for a randomised phase III trial
8    19    1
Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: Evaluation of its early cost-effectiveness

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: Evaluation of its early cost-effectiveness
14    26    1
Diagnostic value of intraoperative ultrasonography in assessing thoracic recurrent laryngeal nerve lymph nodes in patients with esophageal cancer

Diagnostic value of intraoperative ultrasonography in assessing thoracic recurrent laryngeal nerve lymph nodes in patients with esophageal cancer
7    68    0
Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy

Neutrophil-lymphocyte ratio as a predictor of oncologic outcomes in stage IVB, persistent, or recurrent cervical cancer patients treated by chemotherapy
10    58    1
Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance

Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance
9    55    1
Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: Update on a phase II study

Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: Update on a phase II study
8    59    1
The efficiency of 18F-FDG-PET/CT in the assessment of tumor response to preoperative chemoradiation therapy for locally recurrent rectal cancer

The efficiency of 18F-FDG-PET/CT in the assessment of tumor response to preoperative chemoradiation therapy for locally recurrent rectal cancer
10    36    1
Association between age at initial diagnosis and post-metastasis mortality among women with recurrent metastatic breast cancer in China

Association between age at initial diagnosis and post-metastasis mortality among women with recurrent metastatic breast cancer in China
12    12    1
Rucaparib in recurrent ovarian cancer: Real-world experience from the rucaparib early access programme in Spain – A GEICO study

Rucaparib in recurrent ovarian cancer: Real-world experience from the rucaparib early access programme in Spain – A GEICO study
10    9    1
Study protocol for prospective multi-institutional phase III trial of standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC)

Study protocol for prospective multi-institutional phase III trial of standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC)
7    3    1
Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy

Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy
10    75    1
Analysis on GENIE reveals novel recurrent variants that affect molecular diagnosis of sizable number of cancer patients

Analysis on GENIE reveals novel recurrent variants that affect molecular diagnosis of sizable number of cancer patients
12    46    1
Clinical significance of histopathological features of paired recurrent gliomas: A cohort study from a single cancer center

Clinical significance of histopathological features of paired recurrent gliomas: A cohort study from a single cancer center
9    9    1
Sách: Breast Cancer (American cancer society quick facts)

Sách: Breast Cancer (American cancer society quick facts)
330    102    0
Combining therapy with recombinant human endostatin and cytotoxic agents for recurrent disseminated glioblastoma: A retrospective study

Combining therapy with recombinant human endostatin and cytotoxic agents for recurrent disseminated glioblastoma: A retrospective study
8    89    0
VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma

VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma
7    40    1
Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma

Long-term survival and late complications of intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma
8    51    1